CoChat

Berberine for diarrhea in children and adults: a systematic review and meta-analysis

Open access
Yu, Mingkun, Jin, Xuejing, Liang, Changhao, Bu, Fanlong, Pan, Deng, He, Qian, Ming, Yang, Little, Paul, Du, Hongbo, Liang, Shibing, Hu, Ruixue, Li, Chengze, Hu, Yanhong Jessika, Cao, Huijuan, Liu, Jianping, Fei, Yutong · 2020 · Therapeutic Advances in Gastroenterology
Cited by 54

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Background: Diarrhea is a ubiquitous digestive system disease, leading to loss of fluid and electrolytes, and may be life-threatening, especially in children and adults who are immunosuppressed or malnourished. Berberine has a broad-spectrum antibiotic activity and is very widely used to treat diarrhea in China. No systematic review has been carried out to evaluate the evidence presented in clinical trials. The aim of this study was to assess the effectiveness and safety of berberine in diarrhea treatment among children and adults. Methods: Seven databases and two clinical trial registries were searched on 1 September 2019. Randomized controlled trials were included, where participants were diagnosed (first diagnosed) as having diarrhea according to clear diagnostic criteria. Berberine alone or in combination with Western medication as intervention were included. Subgroup analyses were conducted based on children or adults, acute or persistent diarrhea, infectious or noninfectious and treatment courses. Primary outcomes were clinical cure rate and duration of diarrhea. The GRADE tool was used to assess the quality of evidence. Results: A total of 38 randomized controlled trials were included involving 3948 participants (including 27 trials on 2702 children) were included. Compared with antibiotics, berberine plus antibiotics showed better results in both adults and in children in general, especially when given for 7 days or 3 days in acute infectious diarrhea of children. Compared with the control groups, using berberine alone or in combination with montmorillonite, probiotics, and vitamin B increased the clinical cure rate of diarrhea. The use of berberine alone or berberine combined with montmorillonite reduced the duration of hospitalization. Using berberine had significantly better laboratory indicators (isoenzyme, inflammatory factors, myocardial enzyme, and fecal trait) and fewer systemic symptoms than the no berberine groups. Overall, 22 of 27 trials on children used berberine as an enema. No deaths and serious adverse events were reported. The quality of evidence of included trials was moderate to low or very low. The impact of different dosages, frequencies and treatment durations on the outcomes was not evaluated due to insufficient number of trials. Conclusion: This review demonstrated that berberine was generally effective in improving clinical cure rates and shortening the duration of diarrhea compared with control groups. No severe adverse event was reported. However, there is still a lack of high-quality evidence for evaluating the efficacy and safety of berberine. Trial registration: PROSPERO CRD42020151001 (available from http://www.crd.york.ac.uk/PROSPERO/ ).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1756284820961299

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 61

  1. Das JK, 2018, Cochrane Database Syst Rev, 12
  2. 10.1097/MCG.0b013e31826df662 · DOI · Paper page
  3. Pérez-Gaxiola G, 2018, Cochrane Database Syst Rev, 4
  4. Allen SJ, 2010, Cochrane Database Syst Rev, 2010
  5. 10.1002/14651858.CD005436.pub5 · DOI · Paper page
  6. MacGillivray S, 2013, Cochrane Database Syst Rev, 2013
  7. Qingwei Y, 2018, Psychological Monthly, 10
  8. 10.1002/ptr.5693 · DOI · Paper page
  9. Xiao PG, 2016, Mod Chin Med, 18, 1381
  10. 10.1136/bmj.291.6509.1601 · doi:10.1136/bmj.291.6509.1601
  11. 10.1142/S0192415X14500669 · DOI · Paper page
  12. Ukita T, 1949, Jpn J Exp Med, 20, 103
  13. 10.1139/m69-190 · DOI · Paper page
  14. 10.3109/13880209.2010.500295 · doi:10.3109/13880209.2010.500295
  15. 10.1093/infdis/155.5.979 · DOI · Paper page
  16. 10.18388/abp.2017_1621 · DOI
  17. Chen ZY, 1959, J Nanjing Med Univ (Natural Sciences), 233
  18. Shi RY, 1959, J Peking Univ (Health Sciences), 153
  19. 10.1007/BF02818693 · DOI · Paper page
  20. 10.1002/ptr.4926 · DOI
  21. Yang CZ, 2017, Clin Med, 37, 111
  22. Li W, 2017, Everybody Health (First Ten Day Edition), 11, 154
  23. Lin RX, 2016, J Colorectal Anal Surg, 22, 658
  24. Wei H, 2016, Med Front, 6, 358
  25. Wang ZH, 2016, Modern Digestion and Interventional Diagnosis and Treatment, 21, 323
  26. Chen H, 2015, Chin J Biochem Pharmaceuticals, 35, 97
  27. Luo YM, 2014, Clin Res Tradit Chin Med, 6, 110
  28. Ye J, 2013, Chin Med Innov, 10, 51
  29. Zhou Y, 2013, China Health Nutr, 614
  30. Huang YC, 2012, Asia Pac Tradit Med, 8, 137
  31. Fu JQ, 2011, Mod J Integr Tradit Chin West Med, 20, 3567
  32. Huang H, 2010, Chin Community Doct, 12, 84
  33. Li YL, 2010, Nurs Pract Res, 7, 33
  34. Hu YX, 2009, Chin Med Front, 4, 43
  35. Zhao L, 2007, World Health Dig, 4, 46
  36. Xu YF, 2006, J Qiqihar Med Coll, 1751
  37. Zhang HF, 2015, Health Care Today, 75
  38. Dang GL, 2011, Journal of Yan’an University (Medical Science Edition), 9, 52
  39. Wu J, 2001, China J New Drugs Clin Med, 360
  40. Liu H, 2015, Diet Health, 2, 49
  41. Wang YX, 2013, J Front Med, 5, 122
  42. Jin XH, 2012, Chinese Medical Guide, 10, 268
  43. Huang HH, 2011, Chin Pediatr Integr Tradit West Med, 3, 149
  44. Qiu LL, 2010, Chin J Mod Drug Appl, 4, 79
  45. Qin HL, 2010, Chinese and Foreign Medical Research, 8, 32
  46. Gan YL, 2009, Chin J Mod Nurse, 15, 51
  47. Guo XH, 2009, Chin J Mod Drug Appl, 3, 137
  48. Wang HQ, 2009, Chinese Journal of Misdiagnostics, 9, 7852
  49. Zhu HL, 2009, Zhejiang Prev Med, 21, 65
  50. Shi ZL, 2008, China Med Herald, 5, 66
  51. Wan YL, 2007, J Mod Med Health, 23
  52. Liu H, 2015, Diet Health, 2, 49
  53. Li H, 2004, J Nurs Sci, 58
  54. Geng Y, 2012, China Med Pharm, 2, 76
  55. Lu M, 2008, Chinese and Foreign Health Abstracts, Clinician Edition, 5, 87
  56. Yi Q, 2008, China Mod Doct, 46, 89
  57. Han ZZ, 2013, Inner Mongolia Med J, 45, 591
  58. Kang H, 2005, Med Theory Pract, 18, 1193
  59. Song SY, 1999, Chin J Microecology, 4, 70
  60. National Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science and Technology Press, 2015, pp.1243–1244.
  61. 10.1016/j.micpath.2015.11.027 · DOI

Cited by

See all 54

Metadata

Authors
Yu, M., Jin, X., Liang, C., Bu, F., Pan, D., He, Q., Ming, Y., Little, P., Du, H., Liang, S., Hu, R., Li, C., Hu, Y. J., Cao, H., Liu, J., & Fei, Y.
Venue
Therapeutic Advances in Gastroenterology
Published
2020-01
Volume
13
Pages
1756284820961299-1756284820961299
ISSN
  • 1756-283X (ISSN-L)
  • 1756-2848
OpenAlex
W3094596778
Cited by
54
References
2
FWCI
1.34
Type
journal article
Language
en
Open access
gold
Funders
national key research and development program of china stem cell and translational research (No. 2018YFE0102300)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Berberine for diarrhea in children and adults: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1177/1756284820961299
The paper
Yu, M., Jin, X., Liang, C., Bu, F., Pan, D., He, Q., Ming, Y., Little, P., Du, H., Liang, S., Hu, R., Li, C., Hu, Y. J., Cao, H., Liu, J., & Fei, Y. (2020). Berberine for diarrhea in children and adults: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology. https://doi.org/10.1177/1756284820961299

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.